NL-OMON24928尚未招募不适用
Oncolytic adenovirus therapy as an adjuvant treatment for localised prostate cancer.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- Erasmus MC
- 入组人数
- 18
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Men 35-70 years old scheduled to undergo radical prostatectomy in Erasmus MC
- •2. Histologically proven adenocarcinoma of the prostate
排除标准
- •1. Patients with >= 20% risk on lymph node involvement according to the Memorial Sloan-Kettering Cancer Centre (MSKCC) Prostate Cancer Prediction Tool for pre-treatment risk assessment. This tool is available at http://www.mskcc.org/mskcc/html/10088.cfm
- •2. Prior androgen ablation hormonal therapy (except treatment with finasteride - if discontinued > 3 months prior to inclusion in current protocol)
研究者
相似试验
已完成
不适用
Oncolytic adenovirus therapy as an adjuvant treatment for localised prostate cancer.Prostate carcinoma1003859710036958prostate cancerNL-OMON43563Erasmus MC, Universitair Medisch Centrum Rotterdam18
已完成
不适用
Adoptive immunotherapy for adenovirus (AdV)-associated complications post transplantatioCancerISRCTN14732774Charité - University Medicine Berlin (Germany)306
招募中
1 期
OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder CancerNon-muscle-invasive Bladder CancerNCT05232136Binhui Biopharmaceutical Co., Ltd.30
撤回
1 期
Virus-specific ImmunoTherapy Following Allogeneic Stem Cell TransplantationAdenovirus InfectionCytomegalovirus InfectionNCT02702427St. Anna Kinderkrebsforschung
招募中
不适用
Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural MesotheliomaMalignant Pleural Mesothelioma, AdvancedNCT06031636Tianjin Medical University Second Hospital15